CORRECT BLIS forecasts wider 2013 loss, seeks to raise capital

CORRECT BLIS forecasts wider 2013 loss, seeks to raise capital
(Corrects third paragraph to show US company suspended promotions) By Hannah Lynch Aug. 31 (BusinessDesk) - BLIS Technologies, the NZX-listed biotechnology company, widened its forecast 2013 loss and launched a share purchase plan and placement in a bid to raise up to $1.5 million. The Dunedin-based company says its operating loss in the year ending March 31 may be $1.3 million, up from the loss of $800,000 million it affirmed in July. The change reflects a decision by a US-based formulator to suspend the promotion and sales of a product wi...